Imran Khan, the founder of Pakistan Tehreek-e-Insaf (PTI) and former Prime Minister, recently underwent a significant eye treatment at the Pakistan Institute of Medical Sciences (PIMS). This latest medical intervention involved a third injection aimed at addressing his ongoing eye condition. Medical professionals at PIMS conducted a thorough examination after the procedure and reported that his eyesight was in a satisfactory state, providing some reassurance about his health status.
The hospital authorities confirmed that Imran Khan was admitted to the facility with his full consent and cooperation. The treatment consisted of administering a third dose of an anti-VEGF injection, a therapy commonly used to manage retinal diseases by inhibiting abnormal blood vessel growth. This procedure was performed in a fully equipped operation theatre, adhering strictly to all necessary medical protocols and precautionary measures to ensure patient safety.
Following the injection, a specialized medical board evaluated his condition carefully. The panel expressed confidence in the stability of his vision and overall health. Hospital officials emphasized that throughout the treatment, the former premier remained stable and responsive. After the procedure was completed, he was discharged from the hospital the same day, marking another step forward in his ongoing eye care regimen.
This recent treatment is part of a continuing medical process that began when Imran Khan was transferred from Adiala jail to PIMS on February 24. At that time, he received his second anti-VEGF injection after a comprehensive health assessment. Alongside the eye treatment, cardiology evaluations including echocardiography and electrocardiogram tests were conducted, all of which yielded normal results, indicating that his cardiovascular health was stable.
On March 18, a newly formed medical board consisting of five doctors and healthcare staff conducted a detailed health check-up of Imran Khan at Adiala jail. This development followed directives from the Islamabad High Court (IHC), which had instructed the formation of a medical board to closely monitor his condition. Earlier in the month, the IHC also rejected a petition that sought to transfer him to a private hospital, instead directing the chief commissioner of Islamabad to oversee the establishment of the medical board responsible for his care.
It is important to note that Imran Khan has been diagnosed with central retinal vein occlusion (CRVO), a serious eye disorder. This condition arises when the main vein responsible for draining blood from the retina becomes obstructed, leading to vision problems. CRVO is often linked with underlying cardiovascular risk factors such as hypertension, elevated cholesterol levels, diabetes, and heart disease. The diagnosis was detailed in a report submitted to the Supreme Court by his legal team and the court’s amicus curiae, Salman Safdar.
As the former prime minister continues to receive medical attention, his health remains under close observation by both medical experts and judicial authorities. The ongoing treatments and assessments reflect the seriousness with which his condition is being managed, while also highlighting the challenges faced by political figures undergoing health crises during incarceration.
